webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mal-DPEG4-NHS

  CAS No.: 756525-99-2   Cat No.: BADC-00367   Purity: ≥98% 4.5  

Mal-DPEG4-NHS is an advanced biomedical compound that plays a key role in combating multiple diseases and promoting efficient drug delivery mechanisms. As a linker, it can bind therapeutic drugs or biomolecules, allowing for precise targeted delivery to specific anatomical areas of the human body.

Mal-DPEG4-NHS

Structure of 756525-99-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C22H31N3O11
Molecular Weight
513.5
Shipping
Room temperature, or blue ice upon request.
Shipping
Please store the product under the recommended conditions in the Certificate of Analysis.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-17-oxo-4,7,10,13-tetraoxa-16-azanonadecan-1-oate;
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCNC(=O)CCN2C(=O)C=CC2=O
InChI
InChI=1S/C22H31N3O11/c26-17(5-8-24-18(27)1-2-19(24)28)23-7-10-33-12-14-35-16-15-34-13-11-32-9-6-22(31)36-25-20(29)3-4-21(25)30/h1-2H,3-16H2,(H,23,26)
InChIKey
XSRYGQJQNPJNKZ-UHFFFAOYSA-N
Appearance
Soild powder
Shipping
Room temperature, or blue ice upon request.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.

Mal-DPEG4-NHS, a versatile bifunctional crosslinker, finds extensive utility in bioconjugation and bioengineering.

Protein Conjugation: Mal-DPEG4-NHS emerges as a pivotal tool for linking proteins and peptides. Through its NHS ester group’s targeted reaction with primary amines, this compound facilitates the binding of biomolecules like antibodies to a spectrum of surfaces or molecules, amplifying their functionality. The resultant conjugates, whether utilized in assays, imaging, or therapeutics, offer a flexible solution for both research and industrial domains.

Drug Delivery Systems: Transitioning to the field of drug delivery, Mal-DPEG4-NHS assumes a crucial role as a linking agent for attaching therapeutic compounds to specialized delivery systems like nanoparticles or liposomes. By establishing robust covalent bonds, it ensures the precise transport of drugs to specific cells or tissues, optimizing drug effectiveness, mitigating side effects, and ultimately enhancing patient outcomes through targeted delivery strategies.

Surface Modification: Within the context of surface modification, Mal-DPEG4-NHS takes center stage in enhancing the biocompatibility of biomaterial surfaces or introducing functional groups for subsequent reactions. This application holds particular significance in the development of biomedical devices, where surface enhancements play a key role in reducing immune reactions and enhancing device integration. Tailored modifications cater to diverse applications in areas such as tissue engineering, implants, and diagnostics.

Bioimaging: Mal-DPEG4-NHS unfolds its potential in conjugating fluorescent dyes or imaging agents to biomolecules, allowing for their visualization within cellular or tissue environments. This functionality is pivotal in tracking biological processes, diagnosing diseases, or monitoring the effectiveness of therapeutic interventions.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: FR-901464 | Mal-PEG6-NHS | Mal-DPEG4-NHS
Send Inquiry
Verification code
Inquiry Basket